A innovative medication, this compound, is creating significant attention within the healthcare community as a potential solution for weight challenges. Developed by researchers, it’s a dual GIP and GLP-1 receptor agonist, meaning it functions on two separate pathways to regulate appetite and support fat expenditure . Early study findings have de